Assenagon Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.3M | Buy |
1,163,755
+947,865
| +439% | +$34.5M | 0.06% | 220 |
|
|
2025
Q1 | $7.82M | Buy |
215,890
+146,617
| +212% | +$5.31M | 0.01% | 445 |
|
|
2024
Q4 | $2.91M | Sell |
69,273
-76,160
| -52% | -$3.2M | ﹤0.01% | 817 |
|
|
2024
Q3 | $8.08M | Buy |
145,433
+3,259
| +2% | +$181K | 0.01% | 560 |
|
|
2024
Q2 | $5.84M | Hold |
142,174
| – | – | 0.01% | 561 |
|
|
2024
Q1 | $6.64M | Sell |
142,174
-367
| -0.3% | -$17.1K | 0.02% | 505 |
|
|
2023
Q4 | $6.82M | Sell |
142,541
-68,380
| -32% | -$3.27M | 0.02% | 523 |
|
|
2023
Q3 | $7.52M | Sell |
210,921
-23,547
| -10% | -$839K | 0.02% | 430 |
|
|
2023
Q2 | $10.8M | Sell |
234,468
-179,759
| -43% | -$8.29M | 0.04% | 327 |
|
|
2023
Q1 | $16.6M | Buy |
414,227
+254,408
| +159% | +$10.2M | 0.06% | 259 |
|
|
2022
Q4 | $7.4M | Sell |
159,819
-29,275
| -15% | -$1.36M | 0.03% | 415 |
|
|
2022
Q3 | $7.83M | Buy |
189,094
+178,744
| +1,727% | +$7.4M | 0.03% | 376 |
|
|
2022
Q2 | $617K | Buy |
+10,350
| New | +$617K | ﹤0.01% | 1142 |
|
|
2022
Q1 | – | Sell |
-10,454
| Closed | -$879K | – | 1486 |
|
|
2021
Q4 | $879K | Buy |
10,454
+1,346
| +15% | +$113K | ﹤0.01% | 1027 |
|
|
2021
Q3 | $821K | Buy |
+9,108
| New | +$821K | ﹤0.01% | 917 |
|
|
2021
Q1 | – | Sell |
-59,891
| Closed | -$8.29M | – | 1241 |
|
|
2020
Q4 | $8.29M | Buy |
+59,891
| New | +$8.29M | 0.04% | 243 |
|